Some Viruses Elicit Immune Response Before Entering Cell; Suburban Sprawl Could Increase Lyme Disease Infections; Human Pediatric Anesthetics Damage Murine Model Brains

In Brief Courtesy of The Bradford Laboratory, University of Helsinki, Finland Some Viruses Elicit Immune Response Before Entering Cell Human cytomegalovirus triggers an immune response before it actually enters the cell, according to a report from researchers at the University of Wisconsin-Madison and the University of Massachusetts (T. Compton et al., "Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2," J Virol, in press). The immune syste

Written byHarvey Black
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Some Viruses Elicit Immune Response Before Entering Cell

Human cytomegalovirus triggers an immune response before it actually enters the cell, according to a report from researchers at the University of Wisconsin-Madison and the University of Massachusetts (T. Compton et al., "Human cytomegalovirus activates inflammatory cytokine responses via CD14 and toll-like receptor 2," J Virol, in press).

The immune system is activated when the virus comes into contact with toll-like receptors on the cell. "No one knew ... that was even possible," says Teresa Compton, associate professor of oncology at Wisconsin. "People thought the virus actually had to get into the cell and start doing its business before the host knew it was there."

Three other viruses (respiratory syncytial, murine mammary tumor, and measles) also trigger the immune system when they come into contact with the toll-like receptors. "It may be this is a common molecular trigger," says Compton. "We're trying ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies